David Schnell
Fondateur chez Prospect Venture Partners
Profil
David Schnell is the founder and currently holds the position of Managing Director at Prospect Venture Partners, a company he founded in 1997.
He is also currently the Director at Panmira Pharmaceuticals LLC and the Managing Director at Iconica LLC.
In the past, Dr. Schnell has held positions as Director at Neurocrine Biosciences, Inc., Essential Therapeutics, Inc., Emdeon Corp., Senomyx, Inc., Emergent Product Development Seattle, Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Amira Pharmaceuticals, Inc., Kythera Biopharmaceuticals LLC, Lux Biosciences, Inc., Alvine Pharmaceuticals, Inc., NGM Biopharmaceuticals, Inc., Trine Pharmaceuticals, Inc., Rinat Neuroscience Corp., Nora Therapeutics, Inc., Healtheon, Inc., Microcide, Inc., and Sandoz Pharmaceuticals Corp.
Dr. Schnell's education includes an undergraduate degree from Stanford University in 1982, a doctorate from Harvard Medical School in 1987, and a graduate degree from Stanford University School of Medicine in 1982.
Postes actifs de David Schnell
| Sociétés | Poste | Début |
|---|---|---|
Prospect Venture Partners
 Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Fondateur | 01/01/1997 |
Panmira Pharmaceuticals LLC
 Panmira Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Iconica LLC
 Iconica LLC Investment ManagersFinance Iconica LLC (Iconica Partners) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California. | Private Equity Investor | - |
Anciens postes connus de David Schnell
| Sociétés | Poste | Fin |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/06/2021 |
| KYTHERA BIOPHARMACEUTICALS INC | Directeur/Membre du Conseil | 31/12/2014 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Directeur/Membre du Conseil | 26/04/2011 |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 28/10/2010 |
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Directeur/Membre du Conseil | 19/09/2008 |
Formation de David Schnell
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Stanford University School of Medicine | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 20 |
|---|---|
Essential Therapeutics, Inc.
 Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Emdeon Corp.
 Emdeon Corp. Data Processing ServicesTechnology Services Emdeon Corp. offers services to connect physicians, hospitals, pharmacies, insurance providers, and consumers with health care transactions and information retrieval. Its transaction services encompass such tasks as HMO enrollment, referrals, data retrieval, and claims processing; its Medical Manager software helps physicians run their practices. The company was founded in December 1995 and is headquartered in Elmwood Park, NJ. | Technology Services |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Satori Pharmaceuticals, Inc. developed therapeutics for alzheimer's disease. The firm's drug candidates selectively modulated gamma secretase, the enzyme generating the neurotoxic peptides that form amyloid beta plaques the signature of this debilitated disease. The company was founded by Mark A. Findeis and Dennis J. Selkoe in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases. Amira combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient development of novel compounds and effective pre-clinical and clinical program decisions. The firm's team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and various fibrotic diseases. Amira has a partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Finance |
Prospect Venture Partners
Prospect Venture Partners Investment ManagersFinance Prospect Venture Partners (Prospect Venture Partners) is a venture capital firm founded in 1997 by Alexander E. Barkas and David Schnell. The firm is headquartered in Palo Alto, California. | Finance |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Trine Pharmaceuticals, Inc. develops and markets pharmaceutical products. It develops drugs which are used in the areas of renal, gastrointestinal and metabolic diseases. The company is headquartered in Waltham, MA. | Health Technology |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | Health Technology |
Healtheon, Inc.
 Healtheon, Inc. Medical/Nursing ServicesHealth Services Healtheon, Inc. provides medical diagnostic and information technology services to both commercial and government clients. Its services include mobile medical diagnostic services, clinical laboratory testing, professional healthcare staffing, and healthcare information technology services. It offers medical diagnostic and information technology services to health care providers throughout the Continental United States and abroad. The company was founded on January 14, 2003 and is headquartered in New Orleans, LA. | Health Services |
Panmira Pharmaceuticals LLC
Panmira Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Panmira Pharmaceuticals LLC provides drug development programs. It develops pharmaceutical products for inflammatory diseases. The company was founded in September 2011 and is headquartered in San Diego, CA. | Health Technology |
Iconica LLC
Iconica LLC Investment ManagersFinance Iconica LLC (Iconica Partners) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California. | Finance |
Microcide, Inc.
 Microcide, Inc. BiotechnologyHealth Technology Microcide, Inc. is a biotechnology company that develops nontoxic antimicrobial products. The private company is based in Sterling Heights, MI. The company was founded in 1990 by John A Lopes, Rose J. Lopes. | Health Technology |
